GENTAMICIN SULFATE OINTMENT USP, 0.1% | Gentamicin sulfate
Rx only
For Dermatologic Use Only Not For Ophthalmic Use
DESCRIPTION
Gentamicin Sulfate Ointment is a wide spectrum antibiotic preparation for topical administration. Each gram contains 1.0 mg of Gentamicin in a base of White Petrolatum with Methylparaben and Propylparaben as preservatives.
CLINICAL PHARMACOLOGY
Gentamicin sulfate is a wide spectrum antibiotic that provides highly effective topical treatment in primary and secondary bacterial infections of the skin. Gentamicin Sulfate Ointment may clear infections that have not responded to treatment with other topical antibiotic agents. In primary skin infections such as impetigo contagiosa, treatment 3 or 4 times daily with Gentamicin Sulfate Ointment usually clears the lesions promptly. In secondary infections, Gentamicin Sulfate Ointment aids in the treatment of the underlying dermatoses by controlling the infection. Bacteria susceptible to the action of gentamicin sulfate include sensitive strains of Streptococci (group A beta-hemolytic, alpha-hemolytic), Staphylococcus aureus (coagulase positive, coagulase negative, and some penicillinase-producing strains), and the gram-negative bacteria, Pseudomonas aeruginosa, Aerobacter aerogenes, Escherichia coli, Proteus vulgaris, and Kiebsiella pneumoniae.
INDICATIONS AND USAGE
Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial super-infections of fungal or viral infections. Please Note: Gentamicin sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. Gentamicin sulfate is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria. Good results have been obtained in the treatment of infected stasis and other skin ulcers , infected superficial burns, paronychia, infected insect bites and stings, infected lacerations and abrasions, and wounds from minor surgery. Patients sensitive to neomycin can be treated with gentamicin sulfate, although regular observation of patients sensitive to topical antibiotics is advisable when such patients are treated with any topical antibiotic. Gentamicin Sulfate Ointment helps retain moisture and has been useful in infection on dry eczematous or psoriatic skin. Gentamicin Sulfate Ointment may be used in children over one year of age as well as in adults.
CONTRAINDICATIONS
This drug product is contraindicated in individuals with a history of sensitivity to any of its components.
PRECAUTIONS
The use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this condition occurs, or if irritation, sensitization or superinfection develops, treatment with gentamicin sulfate should be discontinued and appropriate therapy instituted.
ADVERSE REACTIONS
In patients with dermatoses treated with gentamicin sulfate, irritation (erythema and pruritis) that did not usually require discontinuance of treatment has been reported in a small percentage of cases. There was no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently with gentamicin sulfate on normal skin. Possible photosensitization has been reported in several patients but could not be elicited in these patients by reapplication of gentamicin sulfate followed by exposure to ultraviolet radiation.
DOSAGE AND ADMINISTRATION
A small amount of Gentamicin Sulfate Ointment should be applied gently to the lesions three or four times daily. The area treated may be covered with a gauze dressing if desired. In impetigo contagiosa, the crusts should be removed before application of gentamicin sulfate to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. Infected stasis ulcers have responded well to treatment with gentamicin sulfate under gelatin packing.
HOW SUPPLIED
Gentamicin Sulfate Ointment USP, 0.1% is supplied in 15 gram tubes NDC 0168-0078-15.
Store at controlled room temperature 15°-30°C (59°-86°F).
E FOUGERA & COA division of Nycomed US Inc.Melville, New York 11747 USA
I27815CR2/08#292
NDC 0168-0078-15
Fougera
GENTAMICIN SULFATE OINTMENT UPS, 0.1%
Rx only
FOR EXTERNAL USE ONLY.NOT FOR OPHTHALMIC USE.
Each gram contains 1.0 mg ofGentamicin in a base of WhitePetrolatum with Methylparabenand Propylparaben as preservatives.
NET WT 15 grams

NDC 0168-0078-15
Fougera
GENTAMICIN SULFATEOINTMENT UPS, 0.1%
Rx only
FOR EXTERNAL USE ONLY.NOT FOR OPHTHALMIC USE.
WARNING: Keep out ofreach of children.
NET WT 15 grams

Manufacturer
E. FOUGERA & Co., A division of Nycomed US Inc.
Active Ingredients
Source
- U.S. National Library of Medicine
- DailyMed
- Last Updated: 4 May 2013
Drugs and Medications
Gentak gentamicin sulfate ophthalmic solution usp, 0.3% [Akorn, Inc.]
GENTAK Gentamicin Sulfate Ophthalmic Solution USP, 0.3%
Gentamicin sulfate [Physicians Total Care, Inc.]
Gentamicin sulfate ophthalmic ointment usp sterile [E. FOUGERA and CO.]
GENTAMICIN SULFATE OPHTHALMIC OINTMENT USP STERILE
Gentamicin sulfate [Perrigo New York Inc]
Gentamicin Sulfate Ointment USP, 0.1%
Gentamicin sulfate [Perrigo New York Inc]
Gentamicin Sulfate Cream USP, 0.1%
Clinical Trials
Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)
This is a parallel-group, randomized, active-controlled, double-blind, Phase 4 trial comparing three creams in the treatment of impetiginous eczema: - Arm A: QUADRIDERME® cream (betam...
Determination of Gentamicin Dosing in Neonatal Patients
The purpose of this study is to determine what dosage of gentamicin for use in one-time administration device (Uniject) is appropriate.
Interest of Gentamicin-Induced Readthrough in Cystic Fibrosis Patients
Suppression of stop mutations in the CFTR gene with parenteral gentamicin can be predicted in vitro and is associated with clinical benefit and significant modification of the CFTR-mediate...
Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
The purpose of this study is to compare the outcome of treatment for bacteremic MRSA infection with vancomycin alone, vancomycin plus gentamicin, vancomycin plus rifampin, and vancomycin p...
Treatment of Chorioamnionitis After Delivery
Chorioamnionitis occurs in 1% to 5% of term pregnancies and may complicate up to 25% of cases of preterm labor. The traditional regimen used to treat intra-amniotic infection is intraveno...
PubMed Articles
A novel methanol derived graphene (MDG) and gentamicin sulfate nanohybrid was prepared, and the loading and release behaviour of gentamicin on MDG is investigated. An efficient drug loading of 2.57 mg...
A simple, reliable, highly sensitive and selective spectrofluorimetric method has been developed for determination of certain aminoglycosides namely amikacin sulfate, tobramycin, neomycin sulfate, gen...
Antimicrobial activity of gentamicin palmitate against high concentrations of Staphylococcus aureus.
The reduction of implant related infections plays a pivotal role in orthopaedic surgery as an increasing number of people require implants (up to 200,000 per year in the United States (source: Joint I...
The influences of sphingolipid metabolites on gentamicin-induced hair cell loss of the rat cochlea.
Sphingolipid metabolites inducing ceramide, sphingosine, and sphingosine-1-phosphate (S1P) play important roles in the regulation of cell proliferation, survival, and death. Aminoglycoside antibiotics...
Are Gentamicin and/or Vancomycin Associated with Ototoxicity in the Neonate? A Retrospective Audit.
Background: Aminoglycoside-induced ototoxicity has been reported in neonates but its incidence is poorly defined, whereas vancomycin-induced ototoxicity has not been reported in neonates. Objective: T...